Duralgina

Product NDC: 53145-013
11-digit product format: 531450013
Labeler code: 53145
Product ID: 53145-013_3a893b13-e7ee-c5b1-e063-6394a90a4253
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen
Dosage form: TABLET
Route: ORAL
Labeler: Menper Distributors Inc.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2017-01-01
Substance: ACETAMINOPHEN
Active strength: 325 mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53145-013-71	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53145-013-71	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53145-013-71	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53145-013-71	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53145-013-71	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53145-013-71	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53145-013-71	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53145-013-71	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53145-013-71	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Duralgina
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACETAMINOPHEN	325 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
313782	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bb31f66c-80a9-4bdb-983b-cef5d21de5ff	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53145-013-71	2020-01-31	C162847	48780-1	9d75b9d0-b84e-f424-e053-dadaa90a57ce	Duralgina

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53145-013-71	Duralgina	30 in 1 BOTTLE	TABLET	30		11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 12 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ACETAMINOPHEN 500 MG	ACETAMINOPHEN	A-S Medication Solutions	92559d65-f5e2-4054-9763-b9c560452dab	2026-05-22	Warnings	Exact identifier application number: M013
Acetaminophen PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	Grocery Outlet, Inc.	441d2629-3fff-0bf1-e063-6394a90aa9b6	2026-05-21	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Grocery Outlet, Inc.	441d1bde-d677-fab7-e063-6394a90aaad4	2026-05-21	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Grocery Outlet, Inc.	441d3a39-cc55-3c7c-e063-6394a90ad7a7	2026-05-21	Warnings	Exact identifier application number: M013
INFANTS Pain and Fever	ACETAMINOPHEN	Aurohealth LLC	b3f57af5-661f-4534-9eed-76e431f338db	2026-05-20	Warnings	Exact identifier application number: M013
Good Sense aspirin	ASPIRIN	L. Perrigo Company	e150dd59-8db8-449f-9c9a-1aa6deb3be2e	2026-05-20	Warnings	Exact identifier application number: M013
Infants Pain and Fever	ACETAMINOPHEN	Aurohealth LLC	e837538d-0515-4f99-b04c-fda63b28777e	2026-05-20	Warnings	Exact identifier application number: M013
Walgreens Headache Relief Extra Strength	ACETAMINOPHEN 250MG, ASPIRIN 250MG AND CAFFEINE 65MG	Walgreens	52109b65-3bf1-de38-e063-6394a90a9727	2026-05-18	Warnings	Exact identifier application number: M013
Genexa Infants Pain and Fever	ACETAMINOPHEN	Genexa Inc.	5220a40d-4a4f-5bad-e063-6394a90a93b0	2026-05-18	Warnings	Exact identifier application number: M013
childrens Pain and Fever	ACETAMINOPHEN	Topco Associates, LLC	7f7b4377-9b40-4a12-808b-f1cd7d241b0d	2026-05-18	Warnings	Exact identifier application number: M013
Aspirin Enteric Coated, Regular Strength	ASPIRIN	Gendose Pharmaceuticals, LLC	10b9a1fc-70d1-44ea-a6de-5c1943e8fbaa	2026-05-15	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Gendose Pharmaceuticals, LLC	119de26f-cce5-401c-81fa-775ebebf6c6f	2026-05-15	Warnings	Exact identifier application number: M013
Aspirin Low Dose Chewable Orange	ASPIRIN	Cardinal Health 107, LLC	827bbe77-febb-4352-892f-3fbb2acfc7d5	2026-05-14	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Topco Associates, LLC	56c125de-fabf-41fa-88a4-760d2793f202	2026-05-13	Warnings	Exact identifier application number: M013
Headache Relief	ACETAMINOPHEN, ASPIRIN, CAFFEINE	Chain Drug Marketing Association, Inc.	17216bf3-bed0-4d7a-994e-76a0e4c79c5c	2026-05-13	Warnings	Exact identifier application number: M013
ACETAMINOPHEN 500 MG	ACETAMINOPHEN	A-S Medication Solutions	c445c6bb-69a8-492e-b100-ce942707f203	2026-05-12	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	Valu Merchandisers Company	1754a9f2-e7e5-4efb-a728-6ba2a7155d11	2026-05-12	Warnings	Exact identifier application number: M013
Menstrual Relief	ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE	Target Corporation	bc65e205-64fd-4764-8c5e-2793af4e9adf	2026-05-12	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	DOLGENCORP, LLC	a7e27000-a26b-46c2-823e-663f4e76db74	2026-05-11	Warnings	Exact identifier application number: M013
Market Basket Effervescent Antacid and Pain Relief	ASPIRIN, CITRIC ACID, SODIUM BICARBONATE	Demoulas Super Markets, Inc.	e15439c7-0e3c-7752-e053-2995a90a1a40	2026-05-11	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313782	acetaminophen 325 MG Oral Tablet	PSN	bb31f66c-80a9-4bdb-983b-cef5d21de5ff	11
313782	acetaminophen 325 MG Oral Tablet	SCD	bb31f66c-80a9-4bdb-983b-cef5d21de5ff	11
313782	APAP 325 MG Oral Tablet	SY	bb31f66c-80a9-4bdb-983b-cef5d21de5ff	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
53145-013-71	53145001371	30 TABLET in 1 BOTTLE (53145-013-71)	30 tablet	2017-01-01	No	No	Current